More seasonal sickness likely in years to come, say experts
With COVID now added to the annual mix of viruses that typically circulate every year, including influenza, respiratory syncytial virus (RSV), and other respiratory viruses, “sick season” is likely to be worse—and longer—going forward.
Precautions urged as coronavirus levels spike in Boston wastewater
With coronavirus levels in Boston-area wastewater increasing ahead of the holiday season, people should get the latest COVID-19 vaccine and use rapid antigen tests if they feel sick, according to experts.
Op-ed: Wastewater testing can help fight flu and RSV
Monitoring wastewater for signs of the influenza virus and respiratory syncytial virus (RSV) could help public officials better respond to upcoming surges this fall and winter, according to Harvard Chan School's Bill Hanage.
COVID update: tests, business readiness, 'new normal'
Although COVID cases have ticked up, there is also good news: Old COVID tests may still be good; businesses should know how to pivot if infections keep climbing; and overall COVID conditions aren't nearly as bad as they…
Experts reflect on COVID-19, share lessons for future pandemics
The U.S. response to the COVID-19 pandemic was full of missteps—ones that experts say can inform preparations for future global health emergencies.
Political ideology of U.S. elected officials linked with COVID-19 health outcomes
Study finds the higher the exposure to political conservatism, the higher the COVID-19 mortality rates and stress on ICU capacity
Tracking and responding to the global monkeypox outbreak
Bill Hanage discusses the current state of the monkeypox outbreak and efforts to control disease spread.
How university screening programs revealed Omicron’s spread
Screening programs at Boston-area universities helped show how quickly the Omicron variant of the coronavirus overtook the Delta variant in the fall of 2021, according to a new study.
Omicron’s ‘milder’ severity likely due to population immunity
The SARS-CoV-2 Omicron variant’s “milder” outcomes are likely due to more population immunity compared to earlier waves of the pandemic, rather than the virus’s properties.
Delta-like SARS-CoV-2 variants are most likely to increase pandemic severity
Delta-like SARS-CoV-2 variants are most likely to increase pandemic severity, according to a new study.
